Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Development of deuterium metabolic imaging to map body biochemistry with MRI

Project description

MRI-based 3D body biochemistry scanning

Until recently, there were no imaging technologies capable of detecting metabolic disturbances in humans in a non-invasive manner. Deuterium metabolic imaging (DMI) has come to revolutionise metabolic monitoring through the use of the non-radioactive and biocompatible deuterium (2H) isotope. The process entails the administration of a deuterium-labelled metabolic substrate such as glucose followed by magnetic resonance spectroscopic imaging. The key objective of the EU-funded BodyDMI project is to generate a DMI setup that could be established in the clinic for measuring patient metabolism. Moreover, researchers will test the feasibility of DMI in diabetes patients, while its application could extend to monitoring cancer treatment.

Objective

The global obesity epidemic has resulted in a dramatic rise in metabolic diseases and the development of effective therapies has greatly lagged behind. This could arguably be attributed to a lack of non-invasive (imaging) techniques to characterize disturbances in metabolic pathways. We will investigate the use of dynamic deuterium metabolic imaging (DMI) to dynamically map body biochemistry in humans in 3D imaging mode. DMI relies on deuterium magnetic resonance spectroscopic imaging combined with oral administration of deuterium-labeled compounds.

The innovation idea is linked to the MCUBE project of FET-OPEN-01-2016-2017. Here a dual-dipole coil was designed for hydrogen MRI at 7 tesla (300 MHz), which outperformed the state-of-the-art setup of the loop-dipole coil for MRI. The new design is transparent to loop designs, meaning that the setup can be combined with loop coils, which are known to be the optimal setup for low frequency operation. So for DMI, which operates at 45.7 MHz (low frequency) at 7 tesla, an MRI coil array can be designed that not only outperforms MRI, but also enables DMI at uncompromised sensitivity within the same scan session, which will complement the utilization of the MCUBE project.

The objectives of the project are: (1) Build and test a body DMI setup for a clinical ultra-high field 7 tesla MRI scanner; (2) demonstrate proof of concept to measure hepatic carbohydrate and lipid metabolism with DMI; and (3) apply DMI in a clinical feasibility study in type 2 diabetes patients. Upon successful completion of the project, DMI will be valorized by the commercial partners and embedded in clinical practice, which opens up a new window for drug studies to directly image their chemical efficacy. Besides its application in metabolic diseases, DMI has potential to detect organ failure, drug toxicity and effects of cancer treatment in a much earlier stage than morphological imaging.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

CSA - Coordination and support action

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-FETOPEN-2018-2020

See all projects funded under this call

Coordinator

UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Net EU contribution
€ 81 250,00
Address
HEIDELBERGLAAN 100
3584 CX Utrecht
Netherlands
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 81 250,00

Participants (2)